Side-by-side financials for CRDF and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRDF | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $593.00K | - |
| Net income (latest FY) | -$45.85K | - |
| Net margin | -7.7% | - |
| SEC filings | 1,000 | 548 |
Full pages: Cardiff Oncology, Inc. and BioNTech SE, or browse the full rankings.